The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N, N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation

• Autores: M. J. Fabis, T. Mikheeva, G. S. Scott, R. B. Kean, J. G. Mabley
• Localización: Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, Vol. 310, Nº. 3, 2004, págs. 1053-1061
• Idioma: inglés
• Texto completo no disponible (Saber más ...)